OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Our participation in the VIB conference: « Revolutionizing Next-Generation Sequencing » 11-12 March 2021 (virtual edition)!

Our participation in the VIB conference: « Revolutionizing Next-Generation Sequencing » 11-12 March 2021 (virtual edition)!
2021-03-10
by Editorial team

This conference aims to bring together experts in both established and novel sequencing technologies along with top scientists in the field.

We were glad to be present at this event as a sponsor during the whole two days event within our exhibitor booth, to meet you, and answer your questions about oncNGS.

Marc Van Den Bulcke, Head of the Belgian Cancer Centre and cooordinator of the oncNGS consortium gave a talk to pitch the oncNGS project.

More info.

Share us on:
  • Home
  • About
  • Phases
  • Open Market Consultation
  • News
  • Contact
  • Login
  • FAQ

Articles récents

  • OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing
  • oncNGS consortium conducted site visits to phase 2 contractors
  • OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer
  • Update on the current stage of the oncNGS Pre-Commercial Procurement procedure
  • The oncNGS consortium selects 4 innovative ideas for the research and development of Next Generation Sequencing solutions for cancer tests

Archives

  • janvier 2025
  • mai 2024
  • septembre 2023
  • février 2023
  • juillet 2022
  • juin 2022
  • mars 2022
  • janvier 2022
  • décembre 2021
  • novembre 2021
  • septembre 2021
  • août 2021
  • juin 2021
  • mai 2021
  • avril 2021
  • mars 2021

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer